Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research
In Their Words

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993

Publications

Harrison, SA, Abdelmalek, MF, Caldwell, S, Shiffman, ML, Diehl, AM, Ghalib, R, Lawitz, EJ, Rockey, DC, Schall, RA, Jia, C, McColgan, BJ, McHutchison, JG, Subramanian, GM, Myers, RP, Younossi, Z, Ratziu, V, Muir, AJ, Afdhal, NH, Goodman, Z, Bosch, J, Sanyal, AJ, and GS-US-321-0105 and GS-US-321-0106 Investigators, . "Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis." Gastroenterology 155, no. 4 (October 2018): 1140-1153.

PMID
29990488
Full Text

Patel, YA, Henson, JB, Wilder, JM, Zheng, J, Chow, S-C, Berg, CL, Knechtle, SJ, and Muir, AJ. "The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis." Clinical Transplantation 32, no. 10 (October 2018): e13388-null.

PMID
30136315
Full Text

Proeschold-Bell, RJ, Evon, DM, Makarushka, C, Wong, JB, Datta, SK, Yao, J, Patkar, AA, Mannelli, P, Hodge, T, Naggie, S, Wilder, JM, Fried, MW, Niedzwiecki, D, and Muir, AJ. "The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial." Contemporary Clinical Trials 72 (September 2018): 73-85.

PMID
30006024
Full Text

Younossi, Z, Stepanova, M, Sanyal, AJ, Harrison, SA, Ratziu, V, Abdelmalek, MF, Diehl, AM, Caldwell, S, Shiffman, ML, Schall, RA, McColgan, B, Subramanian, GM, Myers, RP, Muir, A, Afdhal, NH, Bosch, J, and Goodman, Z. "The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options." Journal of Hepatology (August 23, 2018).

PMID
30144554
Full Text

Nitsche, B, Miller, SC, Giorgio, M, Berry, CA, and Muir, A. "Improving Hepatitis C Identification: Technology Alone Is Not the Answer." Health Promotion Practice 19, no. 4 (July 2018): 506-512.

Full Text

Younossi, ZM, Afendy, A, Stepanova, M, Racila, A, Nader, F, Gomel, R, Safer, R, Lenderking, WR, Skalicky, A, Kleinman, L, Myers, RP, Subramanian, GM, McHutchison, JG, Levy, C, Bowlus, CL, Kowdley, K, and Muir, AJ. "Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO." July 2018.

PMID
29152767
Full Text

Patel, YA, and Muir, AJ. "Editorial: platelet transfusions in cirrhosis-do the risks outweigh the unclear benefits?." Alimentary Pharmacology & Therapeutics 47, no. 11 (June 2018): 1553-1554.

PMID
29878440
Full Text

Wilder, JM, and Muir, A. "Direct acting antivirals for the treatment of hepatitis C in ethnic minority populations." Expert Opinion on Pharmacotherapy 19, no. 5 (March 24, 2018): 451-456. (Review)

Full Text

Jou, JH, and Muir, AJ. "Hepatocellular Carcinoma Surveillance." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 16, no. 1 (January 2018): 19-20.

PMID
28694129
Full Text

Tana, MM, and Muir, AJ. "Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue?." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 16, no. 1 (January 2018): 16-18.

PMID
28694131
Full Text

Pages